Cancer Letters
Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential
Publication date: Available online 19 August 2022Source: Cancer LettersAuthor(s): Yang Wen, Fan Tang, Chongqi Tu, Francis Hornicek, Zhenfeng Duan, Li Min
Cancer Letters
A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice
Publication date: Available online 19 August 2022Source: Cancer LettersAuthor(s): Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, Yuan Chao Xue, Jingchun Zhang, Honglin Luo
Cancer Letters
ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer
Publication date: Available online 20 August 2022Source: Cancer LettersAuthor(s): Chen Zhou, Shoukang Li, Kaijian Bin, Gengdu Qin, Penglin Pan, Dianyun Ren, Yuhan Zhao, Wentao Xia, Jie Chen, Jiaying Liu, Heshui Wu, Yingke Zhou
Cancer Letters
NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A/MEK/ERK/c-Jun/ABCA1 pathway mediated membrane fluidity
Publication date: Available online 19 August 2022Source: Cancer LettersAuthor(s): Yanzhong Wang, Xi Zhou, Yinjiao Lei, Yadong Chu, Xingtong Yu, Qingchao Tong, Tao Zhu, Haitao Yu, Sining Fang, Guoli Li, Linbo Wang, Gavin Y. Wang, Xinyou Xie, Jun Zhang
Cancer Letters
Carboxypeptidase E and its splice variants: Key regulators of growth and metastasis in multiple cancer types
Publication date: Available online 18 August 2022Source: Cancer LettersAuthor(s): Sangeetha Hareendran, Xuyu Yang, Vinay Kumar Sharma, Y. Peng Loh
Cancer Letters
Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity
Publication date: Available online 16 August 2022Source: Cancer LettersAuthor(s): Xueyao Wang, Rui Hu, Zhenwei Song, Huajun Zhao, Zhaoyi Pan, Yujie Feng, Yating Yu, Qiuju Han, Jian Zhang
Cancer Letters
<em>HULC</em> targets the <em>IGF1R</em>–PI3K-AKT axis <em>in trans</em> to promote breast cancer metastasis and cisplatin resistance
Publication date: Available online 15 August 2022Source: Cancer LettersAuthor(s): Lei Zhou, Hui Li, Tingge Sun, Xue Wen, Chao Niu, Min Li, Wei Li, Andrew R. Hoffman, Ji-Fan Hu, Jiuwei Cui
Cancer Letters
Induction of ferroptosis in head and neck cancer: A novel bridgehead for fighting cancer resilience
Publication date: 10 October 2022Source: Cancer Letters, Volume 546Author(s): Jaewang Lee, Jong-Lyel Roh
Cancer Letters
FGFR1/MAPK-directed brachyury activation drives PD-L1-mediated immune evasion to promote lung cancer progression
Publication date: Available online 17 August 2022Source: Cancer LettersAuthor(s): Yunping Hu, Yong Lu, Fei Xing, Wesley Hsu
Cancer Letters
Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma
Publication date: Available online 15 August 2022Source: Cancer LettersAuthor(s): Liangliang Wu, Yi Ge, Yudong Yuan, Hui Li, Huizhi Sun, Chao Xu, Yifei Wang, Tiansuo Zhao, Xiuchao Wang, Jing Liu, Song Gao, Antao Chang, Jihui Hao, Chongbiao Huang